<qa>  What is the OUTLINE of a randomized, open-label, multicenterOUTLINE: This is a randomized, open-label, multicenter study. Patients are stratified according to chemotherapy regimen, Karnofsky performance status 70-80 vs 90-100, and disease stage IIIA vs IIIB. 